Biovest’s publicly-traded shares quoted on newly launched OTCQB Market

Biovest International, Inc. (OTCQB: BVTI), a biotechnology company advancing its personalized cancer vaccine targeting non-Hodgkin's lymphoma, today announced that the Company's publicly-traded shares are now being quoted on the newly launched OTCQB™ Market. The upgraded stock listing is a direct result of Biovest filing its Annual Reports (on Form 10-K) and its Quarterly Reports (on Form 10-Q) with the Securities and Exchange Commission (SEC), as the Company advances plans to emerge from reorganization. Launched in April 2010, the OTCQB is a new market tier for OTC-traded U.S. companies that are registered and reporting with the SEC.

Signaling its plans to emerge from Chapter 11 as a fully reorganized public company, Biovest also announced the filing of its Disclosure Statement with the U.S. Bankruptcy Court for the Middle District of Florida, Tampa Division. The Disclosure Statement, as a supporting document to the previously filed Plan of Reorganization, reflects the Company's restructured business operations, positioning Biovest to execute its strategy to commercialize BiovaxID for the treatment of follicular lymphoma, mantle cell lymphoma and certain other B-cell blood cancers.

According to Biovest's President, Mr. Samuel S. Duffey, "I am proud to report that we continue to timely execute our business plan to emerge from reorganization, and most importantly, to advance our mission of developing needed new treatment options for lymphoma patients. During the reorganization, we have made significant progress, and we are now preparing to aggressively advance our goal of seeking worldwide regulatory approvals for BiovaxID. We're also pleased to again be a fully reporting public company and to be listed on the OTCQB Market, reflecting the beginning of our commitment to reintroduce Biovest to the capital markets as a fully restructured public company. This is an important step toward our ultimate goal of a future listing on a major exchange."

As a result of Biovest's new OTCQB designation, investors can now view real-time stock quotes with market depth (Level 2). Listings may be found at http://www.otcmarkets.com